Rezolute, INC Form 4 insider transactions

Rezolute, Inc. CFO Daron Evans reports purchasing 20,000 shares of common stock at an average price of $1.6915 on March 15, 2024.

Brian Kenneth Roberts, Chief Medical Officer of Rezolute, Inc., reports the acquisition of 10,000 common shares at $1.88 per share on March 14, 2024.

Brian Kenneth Roberts, Chief Medical Officer of Rezolute, Inc., files an amended Form 4 to correct the reported indirect holdings of common shares held by his minor child.

Director Kim Young-Jin reports purchasing additional shares of Rezolute, Inc.

Brian Kenneth Roberts, Chief Medical Officer of Rezolute, Inc., reports purchasing 500 shares of common stock at $1.85 per share on March 7, 2024.

Daron Evans, CFO of Rezolute, Inc., recently purchased 50,000 common shares of the company at an average price of $1.9269.

Rezolute, Inc. CEO Nevan C. Elam purchased 5,000 shares of the company's common stock at a price of $1.68 per share on February 26, 2024.

Brian Kenneth Roberts, Chief Medical Officer of Rezolute, Inc., reports purchasing shares of the company's common stock in two transactions.